Oppenheimer Cuts ServiceNow Price Target, Keeps Outperform Rating
Oppenheimer has adjusted its price target for ServiceNow (NOW) but continues to maintain an "Outperform" rating for the stock.
87 stories found
Oppenheimer has adjusted its price target for ServiceNow (NOW) but continues to maintain an "Outperform" rating for the stock.
Oppenheimer has upgraded Blackstone to an 'Outperform' rating, identifying it as a premier franchise currently available at a bargain price.
Oppenheimer analysts are bullish on Netflix (NFLX), citing higher revenue driven by recent price hikes as a key factor in their positive outlook.
Goldman Sachs' Peter Oppenheimer stated that valuations for technology stocks currently appear attractive to investors.

A new blockbuster movie has recorded the largest premiere of the year so far, becoming the second-biggest non-franchise opening in a decade, behind only 'Oppenheimer', and is currently dominating the US box office.
Oppenheimer has downgraded Freshworks Inc. (FRSH) from an 'Outperform' to a 'Perform' rating, providing reasons for the change in outlook.
Oppenheimer has increased its price target for Netflix shares from $125 to $135.
Amid a stock market sell-off, Wall Street analysts are identifying and recommending specific growth and retail stocks as buying opportunities, with Oppenheimer bullish on Target Hospitality stock and Bank of America betting on Nebius. New reports detail top research calls for various companies, including undervalued large-cap stocks with high-growth grades.

The film 'Project Hail Mary,' starring Ryan Gosling, has continued to shatter box office expectations, earning over $140.9 million globally and $80.5 million domestically, making it Amazon's highest-grossing film debut and the biggest box office debut of 2026, with stellar reviews breaking the studio's 'curse'.
Nyxoah presented details regarding the early U.S. launch of its Genio system and provided an update on reimbursement at the Oppenheimer MedTech Conference 2026.
Oppenheimer has raised its price target for KLA (KLAC) stock to $1,900, signaling a positive outlook for the company.
Oppenheimer has released its top buy and sell ideas, providing investment recommendations across various sectors of the market.
Oppenheimer has increased its price target for Verizon (VZ) to $56, citing a positive outlook on the company's subscriber growth.
Ocugen's stock has seen a significant spike after Oppenheimer issued a new Outperform rating, citing upcoming catalysts for the company.
Oppenheimer has increased its price target for Tarsus Pharmaceuticals, Inc. (TARS) to $105, maintaining an Outperform rating on the stock.
Oppenheimer has upgraded DigitalOcean Holdings, Inc. (DOCN) citing strong Q4 earnings and customer gains as key factors for the positive outlook.
Oppenheimer has reduced its price target for Elastic (ESTC) shares from $100 to $85.

Oppenheimer analysts predict that the global drone market, particularly the 'lower-skies' category, will grow to $400 billion within the next decade, offering investment opportunities.
Multiple financial institutions have updated their price targets and ratings for various companies, reflecting new outlooks on their performance and market conditions.
Axsome Therapeutics discussed the strong performance of its drug Auvelity, its strategy for a 600-representative sales force, and an upcoming PDUFA date at the Oppenheimer Conference.

Oppenheimer sees shares of Oracle rallying 27% from here.
Oppenheimer has raised its price target for Amrize Ltd (AMRZ) to $70 and maintained an Outperform rating on the stock.

Excitement is building for Christopher Nolan’s next film, 'The Odyssey,' following his successful 'Oppenheimer,' as new trailers and spots are released.

Tell Me Lies creator Meaghan Oppenheimer reveals what she believes is next for Lucy and Stephen, in addition to every other main character.

The Tell Me Lies season 3 finale is also a series finale, with creator Meaghan Oppenheimer explaining why this creative decision was made.

According to critics, four modern epic films from the 21st century are considered superior to "Oppenheimer," demonstrating the enduring power of the genre.
Oppenheimer analysts have expressed bullish views on Marvell Technology's growth outlook, indicating positive prospects for the company.
Investment firm Blackstone has received an upgrade to 'Outperform' from Oppenheimer, indicating a positive outlook on its stock performance.
Broadcom (AVGO) has been identified as one of Oppenheimer's top stock picks. This endorsement suggests strong confidence from the investment firm in Broadcom's future performance.
Goldman Sachs' Oppenheimer has expressed the view that valuations for technology stocks are currently attractive. This assessment provides an analyst's perspective on the tech market.
Oppenheimer has reaffirmed its 'Outperform' rating for AppLovin (APP) stock, maintaining a price target of $660.
Nvidia stock is trading at parity with the S&P 500, prompting discussions among investors about whether to buy the dip, with some analysts like Oppenheimer betting on it alongside other tech stocks, while Cathie Wood has been selling her shares.
Oppenheimer has identified Nvidia, Broadcom, Monolithic Power, and Marvell as its top stock selections within the semiconductor industry.
Oppenheimer has upgraded Freshpet (FRPT) stock to an 'Outperform' rating, signaling a positive outlook for the company.

EXCLUSIVE: Josh Peck has signed with Gersh for representation. Peck recently appeared in the HBO series The Last of Us as Janowicz and in Christopher Nolan’s Oppenheimer, playing real-life physicist…
A new work titled 'Dit vuur' (This Fire) examines the complex legacy of physicist Robert Oppenheimer, questioning whether he was a creator or a destroyer.

Oppenheimer suggests that artificial intelligence will lead to a 'blue-collar renaissance,' as automation increasingly impacts office jobs and boosts physical trades.
InMode, a medical technology company, discussed operational disruptions in Israel, its 60% capacity, and plans for a $600 million share buyback during an Oppenheimer conference.

Authors Eliezer Yudkowsky and Nate Soares warn about a potential 'Trinity moment' for artificial intelligence, drawing parallels to the serious doubts Oppenheimer and his team had about the real risks of the atomic bomb.
Oppenheimer analysts believe that Lennox International Inc. (LII) has set realistic and achievable financial targets for the year 2030.
Oppenheimer has adjusted its target price for CarGurus (CARG) stock downwards to $38.
Oppenheimer has increased its price target for Block, Inc. (XYZ) from $85 to $89.
Oppenheimer has highlighted several stocks, including Apple (AAPL), Alcoa (AA), Baker Hughes (BKR), and Amgen (AMGN), as top performers for momentum.
Oppenheimer has reduced its price target for Zscaler (ZS) shares from $345 to $280.
Innoviva's CEO outlined a three-part growth strategy, a $125 million share buyback, and key catalysts for 2026 during the Oppenheimer Conference.

Il premio Oscar Cillian Murphy ama i personaggi in crisi. Come Oppenheimer o come Tommy Shelby, che torna a interpretare nel film sui Peaky Blinders. Ma poi si porta a casa le inquietudini dei ruoli?
An Oppenheimer analyst has turned bullish on Oracle’s stock after a selloff that has wiped away more than half the company’s value since its September peak.
Cantor and Oppenheimer have maintained a positive outlook on Aurora (AUR), suggesting continued confidence in the company's performance.
Several financial firms have raised their price targets for individual companies, including Diebold Nixdorf, SharkNinja, The Williams Companies, and FedEx, indicating positive outlooks for these stocks.
"My brain just works in a really twisty, worst-case-scenario way," she tells The Hollywood Reporter, while also keeping the door open for spinoffs.
Oppenheimer reports that CrowdStrike remains a top security vendor, while Palo Alto and SentinelOne are also improving their positions in the market.
This cluster includes news on analyst ratings, significant investment filings, regulatory compliance, proposed rights issues, and new business orders for individual companies.
Allbirds' stock experienced a significant surge, reportedly up to 800%, after the company announced its focus on artificial intelligence. However, these gains quickly reversed, with shares sinking as the AI-driven rally came to a halt.

Investment firm Oppenheimer has issued an outperform rating on a specific semiconductor stock, predicting further upside potential driven by the artificial intelligence boom.

Cinema United has established a new Filmmaker Leadership Council, with producers Jerry Bruckheimer and Emma Thomas appointed as its leaders. The council also includes notable filmmakers such as Ryan Coogler, Brad Bird, and Jason Reitman.
According to Peter Oppenheimer of Goldman Sachs, the technology sector is currently experiencing one of its weakest periods of relative returns in the last 50 years.
Oppenheimer and Needham have both raised their price targets for Ultra Clean (UCTT), indicating an optimistic assessment of the company's future performance.
Oppenheimer has reduced its target for WisdomTree, Inc. (WT), while viewing the Atlantic House deal as strategic and accretive.
Oppenheimer is reportedly placing investment bets on several technology stocks, including Monolithic Power, Nvidia, and Marvell, as part of its current market strategy.
Oppenheimer analysts are forecasting a potential rally of up to 560% for two specific stocks that they have rated as 'Strong Buy' opportunities.
According to Oppenheimer, Cloudflare is expected to gain significant advantages from the increasing adoption and development of AI agents.
Oppenheimer has reiterated its 'Perform' rating on Meta Platforms (META) stock, maintaining its stance on the social media giant's shares.
The Pennant Group highlighted its recent acquisition momentum and provided conservative guidance during an Oppenheimer Healthcare Chat, signaling its strategic direction.
Lindblad Expeditions has been identified as a 'compelling' investment opportunity by Oppenheimer, suggesting strong potential for investors.
Oppenheimer has initiated coverage of CoreWeave (CRWV) with a 'Buy' rating, signaling a positive outlook on the company's prospects.
Following its Q4 results, Freshworks Inc. (FRSH) has seen its price targets cut by Citizens and Oppenheimer, reflecting a more cautious analyst outlook.
Telsey Advisory has raised its price target for Costco Wholesale Corporation (COST) from $1,100 to $1,125.
Oppenheimer has initiated coverage of CoreWeave with an Outperform rating, citing the company's long-term potential in the cloud computing and AI infrastructure market.
Oppenheimer analysts project that Oracle's stock could see a 25% increase from its current valuation.
Oppenheimer has reduced its price target for Intuit (INTU) shares from $696 to $558.
Oppenheimer and Tigress Financial Partners maintain a positive outlook on Mobileye (MBLY), signaling confidence in the company's performance.
Oppenheimer suggests two specific beaten-down stocks that could potentially stage a comeback in the market.
Oppenheimer has raised its guidance for Itron, Inc. (ITRI) after the company provided a better-than-expected outlook for fiscal year 2026.
Oracle's stock has increased following an upgrade from Oppenheimer.
Oppenheimer's recent channel checks suggest a favorable future for two specific cybersecurity stocks, leading to a positive market outlook for them.

Tell Me Lies is going out with a bang. The Season 3 finale, which showrunner Meaghan Oppenheimer says is the series conclusion, drew more than 3.5M views in just its first day on Disney+ and Hulu. That’s up nearly 70% from the Season 3 premiere’s same-day audience, Disney says. Deadline previously reported exclusively that the […]

Warning: This article contains spoilers for Tell Me Lies. Meaghan Oppenheimer is telling truths, and you may not want to hear what she has to say. Indeed, the Tell Me Lies showrunner revealed...

Creator Meaghan Oppenheimer has confirmed that the series 'Tell Me Lies' will conclude with its third season, having reached its 'intentional ending'.
Analysts have upgraded the stock ratings for Robinhood, Roku, and Intellia, citing attractive valuations, new collaborations, and positive clinical trial developments.